Abstract:Objective: To quantify emphysema and air trapping at inspiratory and expiratory phase multi-slice spiral CT(MSCT) scanning in smokers without respiratory symptoms, and analyze the correlation between the CT quantifiable parameters and lung function parameters. Methods: A total of 72 smokers, who underwent medical examinations from September 2013 to September 2016 in Changzheng Hospital were enrolled in this research and were divided into two groups: 24 smokers with COPD and 48 smokers without COPD.Besides, thirty-nine non-smokers with normal pulmonary function were enrolled as the controls.All subjects underwent double phase MSCT scanning and pulmonary function tests.CT quantifiable parameters of emphysema included the low attenuation area below a threshold of -950 Hounsfield Units (HU)(LAA%(-950)), the lowest 15th percentile of the histogram of end-inspiratory attenuation values (P(15-IN)), the lowest 15th percentile of the histogram of end-expiratory attenuation values (P(15-EX)), relative volume change(RVC) and the expiratory to inspiratory ratio of mean lung density (E/I(MLD)). Pulmonary function parameters included forced expiratory volume in 1 second expressed as percent predicted (FEV(1)%), forced expiratory volume in one second to forced vital capacity ratio (FEV(1)/FVC), residual volume to total lung capacity ratio (RV/TLC) and carbon monoxide diffusion capacity corrected for alveolar volume (DLCO/VA). The differences of CT quantifiable parameters and pulmonary function parameters among the three groups were analyzed by using one-way analysis of variance or Kruskal-Wallis H test.The correlation between CT quantifiable parameters and pulmonary function parameters was analyzed by using Spearman's correlation analysis. Results: The differences of LAA%(-950)(the values for the controls, the group of smokers with out COPD and the group of smokers with COPD were 0.5%±0.7%, 0.7%±1.2% and 2.0%±2.4% respectively), P(15-IN)(the values of the three groups were (-892±33), (-905±15) and (-907±22) HU respectively), FEV(1)%(the values of the three groups were 88.4%±8.8%, 84.2%±7.5% and 82.1%±8.0% respectively), FEV(1)/FVC(the values of the three groups were 78.0%±3.8%, 76.6%±4.3% and 67.3%±5.5% respectively), DLCO/VA (the values of the three groups were (1.36±0.25), (1.30±0.22) and (1.21±0.22) mmol·min(-1)·kPa(-1)·L(-1) respectively) and RV/TLC (the values of the three groups were 49.5%±6.6%, 45.9%±6.0% and 53.0%±6.4% respectively) among the three groups were statistically significant (all P<0.05). In the control group, LAA%(-950) negatively correlated with FEV(1)/FVC and DLCO/VA(r=-0.32, P=0.04; r=-0.69, P=0.00) and neither did P(15-IN) with FEV(1)%(r=-0.14, P=0.02). Inversely, P(15-IN) positively correlated with DLCO/VA (r=0.55, P=0.00). In the group of smokers without COPD, LAA%(-950) negatively correlated with FEV(1)/FVC and DLCO/VA(r=-0.31, P=0.04; r=-0.42, P=0.00), and P(15-IN) positively correlated with FEV(1)/FVC and DLCO/VA (r=0.33, P=0.02; r=0.30, P=0.04). In the group of smokers with COPD, LAA%(-950) negatively correlated with DLCO/VA (r=-0.62, P=0.00), but positively correlated with RV/TLC (r=0.59, P=0.00). And P(15-IN) positively correlated with DLCO/VA(r=0.53, P=0.01). Conclusions: Smokers emphysema and air trapping can be effectively evaluated by double phase MSCT. Moreover, two of the CT quantifiable parameters, LAA%(-950) and P(15-IN), are highly sensitive to changes in pulmonary function.

Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers

Association of Acute Respiratory Disease Events with Quantitative Interstitial Abnormality Progression at CT in Individuals with a History of Smoking

Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study

[Quantitative Analysis of Emphysema and Air Trapping at Inspiratory and Expiratory Phase Multi-Slice Spiral CT Scan in Smokers: Correlation with Pulmonary Function Test].

Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort

Quantifying the spatial clustering characteristics of radiographic emphysema explains variability in pulmonary function

Serum Amino Acid Concentrations and Clinical Outcomes in Smokers: SPIROMICS Metabolomics Study

Altered White Matter Integrity in Smokers is Associated with Smoking Cessation Outcomes

Morphological and volumetric quantitative assessment of smokers by pulmonary MDCT scan and the correlation with pulmonary function

Metabolomics Profiles of Smokers from Two Ethnic Groups with Differing Lung Cancer Risk

Gut microbiota composition and metabolite profiling in smokers: a comparative study between emphysema and asymptomatic individuals with therapeutic implications

Proteomic networks and related genetic variants associated with smoking and chronic obstructive pulmonary disease

Quantitative study on the degree of small airway disease and emphysema injury in pulmonary lobes of patients with smoking combined with chronic obstructive pulmonary disease based on biphasic CT

Quantitative CT Imaging Features Associated with Stable PRISm using Machine Learning

Metabolic profiling reveals distinct variations linked to nicotine consumption in humans--first results from the KORA study.

Metabolic Differences Between Ex-Smokers and Nonsmokers: A Metabolomic Analysis.

DNA methylation profiling in peripheral lung tissues of smokers and patients with COPD

Abstract LB136: Global metabolomics identified promising biomarkers for lung cancer risk among former smokers

Metabolic alterations caused by smoking: the use of 1H-NMR in blood plasma analysis to unravel underlying mechanisms of lung cancers leading risk factor

Radiographic Emphysema, Circulating Bone Biomarkers, and Progressive Bone Mineral Density Loss in Smokers

Alterations of regional alveolar oxygen tension in asymptomatic current smokers: assessment with hyperpolarized (3)He MR imaging